Number needed to treat and number needed to harm are not the best way to report and assess the results of randomised clinical trials
- PMID: 19438480
- DOI: 10.1111/j.1365-2141.2009.07707.x
Number needed to treat and number needed to harm are not the best way to report and assess the results of randomised clinical trials
Abstract
The inverse of the difference between rates, called the 'number needed to treat' (NNT), was suggested 20 years ago as a good way to present the results of comparisons of success or failure under different therapies. Such comparisons usually arise in randomised controlled trials and meta-analysis. This article reviews the claims made about this statistic, and the problems associated with it. Methods that have been proposed for confidence intervals are evaluated, and shown to be erroneous. We suggest that giving the baseline risk, and the difference in success or event rates, the 'absolute risk reduction', is preferable to the number needed to treat, for both theoretical and practical reasons.
Similar articles
-
Evidence-based dermatology: number needed to treat and its relation to other risk measures.J Am Acad Dermatol. 2007 Apr;56(4):664-71. doi: 10.1016/j.jaad.2006.08.024. Epub 2006 Oct 27. J Am Acad Dermatol. 2007. PMID: 17367615 Review.
-
Improving the calculation of confidence intervals for the number needed to treat.Stud Health Technol Inform. 2000;77:29-32. Stud Health Technol Inform. 2000. PMID: 11187559
-
Interpretation of absolute measures of disease risk in comparative research.Fam Med. 2007 Jun;39(6):432-5. Fam Med. 2007. PMID: 17549653
-
Number needed to treat estimates incorporating effects over the entire range of clinical outcomes: novel derivation method and application to thrombolytic therapy for acute stroke.Arch Neurol. 2004 Jul;61(7):1066-70. doi: 10.1001/archneur.61.7.1066. Arch Neurol. 2004. PMID: 15262737
-
[Numbers needed for treatment and their respective confidence intervals: useful tools to assess clinical significance and uncertainty associated with medical interventions].Rev Port Cardiol. 2000 Dec;19(12):1303-8. Rev Port Cardiol. 2000. PMID: 11220124 Review. Portuguese.
Cited by
-
Modafinil for people with schizophrenia or related disorders.Cochrane Database Syst Rev. 2019 Dec 12;12(12):CD008661. doi: 10.1002/14651858.CD008661.pub2. Cochrane Database Syst Rev. 2019. PMID: 31828767 Free PMC article.
-
Cognitive behavioural therapy without medication for schizophrenia.Cochrane Database Syst Rev. 2024 Feb 7;2(2):CD015332. doi: 10.1002/14651858.CD015332.pub2. Cochrane Database Syst Rev. 2024. PMID: 38323679 Free PMC article.
-
Increasing antipsychotic dose versus switching antipsychotic for non response in schizophrenia.Cochrane Database Syst Rev. 2018 May 11;5(5):CD011884. doi: 10.1002/14651858.CD011884.pub2. Cochrane Database Syst Rev. 2018. PMID: 29749607 Free PMC article.
-
Wendan decoction (Traditional Chinese medicine) for schizophrenia.Cochrane Database Syst Rev. 2017 Jun 28;6(6):CD012217. doi: 10.1002/14651858.CD012217.pub2. Cochrane Database Syst Rev. 2017. PMID: 28657646 Free PMC article.
-
Antiglucocorticoid and related treatments for psychosis.Cochrane Database Syst Rev. 2016 Jan 4;2016(1):CD006995. doi: 10.1002/14651858.CD006995.pub2. Cochrane Database Syst Rev. 2016. PMID: 26725721 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources